Jeffrey V. Poulton Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity
Jeffrey V. Poulton is EVP, Chief Financial Officer of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 28,892 shares of ALNY, which is worth approximately $7.37 Million. The most recent transaction as insider was on Jun 25, 2024, when has been sold 1,605 shares (Common Stock) at a price of $229.42 per share, resulting in proceeds of $368,219. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
28.9K
6.15%
3M change
146.81%
12M change
Total Value Held
$7.37 Million
Jeffrey V. Poulton Transaction History
Also insider at
JVP
Jeffrey V. Poulton
EVP, Chief Financial Officer
Cambridge, MA